Differential expression of Borrelia burgdorferi genes during erythema migrans and Lyme arthritis

Journal of Infectious Diseases

Volumn 178, Issue 4, 1998, Pages 1198-1201

  Fikrig, Erol ^a   Feng, Wen ^a   Aversa, John ^a   Schoen, Robert T ^a   Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL GENE; BORRELIA BURGDORFERI; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYME DISEASE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SYNOVIUM; TICK;

EID: 0031662742     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515684     Document Type: Article

References (15)

1. de Silva AM, Telford SR, Brunet LR, Barthold SW, Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 1996;183:271-5.
2. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci USA 1995;92:2909-13.
3. Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL. Plasminogen is required for efficient dissemination of Borrelia burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 1997; 89:1111-9.
4. Champion CI, Blanco DR, Skare JT, et al. A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection. Infect Immun 1994;62: 2653-61.
5. Akins D, Porcella SR, Popova TG, et al. Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue. Mol Microbiol 1996;18:507-20.
6. Fikrig E, Barthold SW, Sun W, Feng W, Telford SR, Flavell RA. Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity 1997;6:531-9.
7. Zhang JR, Hardham JM, Barbour AG, Morris SJ. Antigenic variation in Lyme disease borreliae by promiscuous recombination of Vmp-like sequence cassettes. Cell 1997;89:275-85.
8. Stevenson, B, Tilly K, Rosa PA. A family of genes located on four separate 32-kilobase circular plasmids in Borrelia burgdorferi B31. J Bacteriol 1996;178:3508-16.
9. Suk K, Das S, Sun W, et al. Borrelia burgdorferi genes selectively expressed in the infected host. Proc Natl Acad Sci (USA) 1995;92:4269-73.
10. Montgomery RR, Malawista SE, Feen KJ, Bockenstedt LK. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J Exp Med 1996;183:261-9.
11. Keller D, Koster FT, Marks DH, Hosbach P, Erdile LF, Mays JP. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine. JAMA 1994;271:1764-8.
12. Kalish R, Leong JM, Steere AC. Association of treatment-resistant chronic Lyme arthritis with antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 1993;61:2774-9.
13. Schutzer SE, Coyle PK, Dunn JJ, Luft BJ, Brunner M. Early and specific antibody responses to OspA in Lyme disease. J Clin Invest 1994;94: 454-7.
14. Schutzer SE, Coyle PK, Krupp LB, et al. Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease. J Clin Invest 1997;100:763-7.
15. Fikrig E, Huguenel ED, Berland R, Rahn DW, Hardin JA, Flavell RA. Serologic diagnosis of Lyme disease using recombinant outer surface proteins A and B and flagellin. J Infect Dis 1992;165:1127-32.